Travere Therapeutics, Inc. financial data

Symbol
TVTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
3611 Valley Centre Dr, Suite 300, San Diego, CA
State of incorporation
California
Fiscal year end
December 31
Former names
Retrophin, Inc. (to 11/13/2020), Desert Gateway, Inc. (to 2/19/2013)
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 352 % -12.4%
Quick Ratio 24 % +248%
Debt-to-equity 398 % -28.4%
Return On Equity -102 % +62.6%
Return On Assets -20.6 % +50.7%
Operating Margin -222 % +27.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 76.5M shares +1.97%
Common Stock, Shares, Outstanding 76.5M shares +1.98%
Entity Public Float 1.15B USD -25.6%
Common Stock, Value, Issued 8K USD +14.3%
Weighted Average Number of Shares Outstanding, Basic 77.5M shares +1.97%
Weighted Average Number of Shares Outstanding, Diluted 77.5M shares +1.97%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 178M USD +47.4%
Research and Development Expense 7.5M USD
Costs and Expenses 571M USD +16.3%
Operating Income (Loss) -394M USD -6.24%
Nonoperating Income (Expense) 10.7M USD +263%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -383M USD -4.15%
Income Tax Expense (Benefit) 356K USD +1.43%
Net Income (Loss) Attributable to Parent -146M USD +52.5%
Earnings Per Share, Basic -1.88 USD/shares +58.4%
Earnings Per Share, Diluted -1.88 USD/shares +58.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 32.3M USD -54.4%
Accounts Receivable, after Allowance for Credit Loss, Current 24.5M USD +19.9%
Inventory, Net 43M USD +129%
Assets, Current 369M USD -31.9%
Property, Plant and Equipment, Net 6.58M USD -23.2%
Operating Lease, Right-of-Use Asset 16.5M USD -15.8%
Intangible Assets, Net (Excluding Goodwill) 105M USD -31.9%
Goodwill 800K USD -11.1%
Other Assets, Noncurrent 16.9M USD +43.5%
Assets 551M USD -25.2%
Accounts Payable, Current 25.8M USD +29.8%
Accrued Liabilities, Current 79.6M USD -10.3%
Contract with Customer, Liability, Current 5.38M USD -47.5%
Liabilities, Current 121M USD -10.6%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 19.9M USD -20.6%
Other Liabilities, Noncurrent 16.6M USD +90.5%
Liabilities 536M USD -13.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.63M USD +57.6%
Retained Earnings (Accumulated Deficit) -1.33B USD -12.3%
Stockholders' Equity Attributable to Parent 15.1M USD -87%
Liabilities and Equity 551M USD -25.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -119M USD -46.7%
Net Cash Provided by (Used in) Financing Activities -525K USD -100%
Net Cash Provided by (Used in) Investing Activities 105M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 76.5M shares +1.98%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.9M USD -115%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 32.3M USD -54.4%
Deferred Tax Assets, Valuation Allowance 291M USD -0.93%
Deferred Tax Assets, Gross 296M USD -1.26%
Operating Lease, Liability 25.1M USD -15.7%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -144M USD +53.7%
Lessee, Operating Lease, Liability, to be Paid 28.7M USD -18.3%
Property, Plant and Equipment, Gross 14.9M USD +4.76%
Operating Lease, Liability, Current 5.16M USD +10.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.89M USD +3.24%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.67M USD +2.65%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.57M USD -32.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.06M USD +2.54%
Deferred Tax Assets, Operating Loss Carryforwards 81.5M USD +63.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 22.9M USD +99.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.78M USD -32.3%
Additional Paid in Capital 1.35B USD +3.24%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 39.1M USD +86.8%
Depreciation, Depletion and Amortization 9.88M USD +49.2%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 39.1M USD -7.03%
Interest Expense 11.2M USD -1.75%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%